Tags

Type your tag names separated by a space and hit enter

Congress responds to the IOM drug safety report--in full.
JAMA. 2007 Nov 14; 298(18):2185-7.JAMA

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Psaty BM
Cardiovascular Health Research Unit, Department of Medicine, University of Washington, and Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA. psaty@u.washington.edu
Korn D
No affiliation info available

MeSH

Clinical Trials as TopicConflict of InterestDatabases, FactualDrug ApprovalDrug-Related Side Effects and Adverse ReactionsNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine DivisionPoliticsProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

18000202

Citation

Psaty, Bruce M., and David Korn. "Congress Responds to the IOM Drug Safety Report--in Full." JAMA, vol. 298, no. 18, 2007, pp. 2185-7.
Psaty BM, Korn D. Congress responds to the IOM drug safety report--in full. JAMA. 2007;298(18):2185-7.
Psaty, B. M., & Korn, D. (2007). Congress responds to the IOM drug safety report--in full. JAMA, 298(18), 2185-7.
Psaty BM, Korn D. Congress Responds to the IOM Drug Safety Report--in Full. JAMA. 2007 Nov 14;298(18):2185-7. PubMed PMID: 18000202.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Congress responds to the IOM drug safety report--in full. AU - Psaty,Bruce M, AU - Korn,David, PY - 2007/11/15/pubmed PY - 2007/12/6/medline PY - 2007/11/15/entrez SP - 2185 EP - 7 JF - JAMA JO - JAMA VL - 298 IS - 18 SN - 1538-3598 UR - https://www.unboundmedicine.com/medline/citation/18000202/Congress_responds_to_the_IOM_drug_safety_report__in_full_ L2 - https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.298.18.2185 DB - PRIME DP - Unbound Medicine ER -